Search Results - "CULLEN, L."

Refine Results
  1. 1

    Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics by Schmid, Cullen L., Kennedy, Nicole M., Ross, Nicolette C., Lovell, Kimberly M., Yue, Zhizhou, Morgenweck, Jenny, Cameron, Michael D., Bannister, Thomas D., Bohn, Laura M.

    Published in Cell (16-11-2017)
    “…Biased agonism has been proposed as a means to separate desirable and adverse drug responses downstream of G protein-coupled receptor (GPCR) targets. Herein,…”
    Get full text
    Journal Article
  2. 2

    Ligand and Target Discovery by Fragment-Based Screening in Human Cells by Parker, Christopher G., Galmozzi, Andrea, Wang, Yujia, Correia, Bruno E., Sasaki, Kenji, Joslyn, Christopher M., Kim, Arthur S., Cavallaro, Cullen L., Lawrence, R. Michael, Johnson, Stephen R., Narvaiza, Iñigo, Saez, Enrique, Cravatt, Benjamin F.

    Published in Cell (26-01-2017)
    “…Advances in the synthesis and screening of small-molecule libraries have accelerated the discovery of chemical probes for studying biological processes. Still,…”
    Get full text
    Journal Article
  3. 3

    Diversification of Acrylamide Polymers via Direct Transamidation of Unactivated Tertiary Amides by Trachsel, Lucca, Konar, Debabrata, Hillman, Jason D., Davidson, Cullen L. G., Sumerlin, Brent S.

    Published in Journal of the American Chemical Society (17-01-2024)
    “…Postpolymerization modification offers a versatile strategy for synthesizing complex macromolecules, yet modifying acrylamide polymers like…”
    Get full text
    Journal Article
  4. 4
  5. 5

    How Does Transcranial Magnetic Stimulation Influence Glial Cells in the Central Nervous System? by Cullen, Carlie L, Young, Kaylene M

    Published in Frontiers in neural circuits (05-04-2016)
    “…Transcranial magnetic stimulation (TMS) is widely used in the clinic, and while it has a direct effect on neuronal excitability, the beneficial effects…”
    Get full text
    Journal Article
  6. 6

    Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria by Brust, Tarsis F, Morgenweck, Jenny, Kim, Susy A, Rose, Jamie H, Locke, Jason L, Schmid, Cullen L, Zhou, Lei, Stahl, Edward L, Cameron, Michael D, Scarry, Sarah M, Aubé, Jeffrey, Jones, Sara R, Martin, Thomas J, Bohn, Laura M

    Published in Science signaling (29-11-2016)
    “…Agonists targeting the kappa opioid receptor (KOR) have been promising therapeutic candidates because of their efficacy for treating intractable itch and…”
    Get more information
    Journal Article
  7. 7

    Low Density Lipoprotein-Receptor Related Protein 1 Is Differentially Expressed by Neuronal and Glial Populations in the Developing and Mature Mouse Central Nervous System by Auderset, Loic, Cullen, Carlie L, Young, Kaylene M

    Published in PloS one (09-06-2016)
    “…The low density lipoprotein-receptor related protein 1 (LRP1) is a large endocytic cell surface receptor that is known to interact with a variety of ligands,…”
    Get full text
    Journal Article
  8. 8

    Collective and network approaches to leadership: Special issue introduction by Cullen-Lester, Kristin L., Yammarino, Francis J.

    Published in The Leadership quarterly (01-04-2016)
    “…In this introduction to the special issue on collective and network approaches to leadership, we begin by discussing the state of research and practice in this…”
    Get full text
    Journal Article
  9. 9

    Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance by Raehal, Kirsten M, Schmid, Cullen L, Groer, Chad E, Bohn, Laura M

    Published in Pharmacological reviews (01-12-2011)
    “…Opioids are the most effective analgesic drugs for the management of moderate or severe pain, yet their clinical use is often limited because of the onset of…”
    Get full text
    Journal Article
  10. 10

    Serotonin, But Not N -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo by Schmid, Cullen L., Bohn, Laura M.

    Published in The Journal of neuroscience (06-10-2010)
    “…Hallucinogens mediate many of their psychoactive effects by activating serotonin 2A receptors (5-HT 2A R). Although serotonin is the cognate endogenous…”
    Get full text
    Journal Article
  11. 11

    Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo by Schmid, Cullen L, Raehal, Kirsten M, Bohn, Laura M

    “…Visual and auditory hallucinations accompany certain neuropsychiatric disorders, such as schizophrenia, and they also can be induced by the use or abuse of…”
    Get full text
    Journal Article
  12. 12

    Employees' Adaptability and Perceptions of Change-Related Uncertainty: Implications for Perceived Organizational Support, Job Satisfaction, and Performance by Cullen, Kristin L., Edwards, Bryan D., Casper, Wm. Camron, Gue, Kevin R.

    Published in Journal of business and psychology (01-06-2014)
    “…Purpose The literature on organizational change has increasingly recognized that characteristics of change recipients influence their reactions to workplace…”
    Get full text
    Journal Article
  13. 13

    Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain by Pantouli, Fani, Grim, Travis W., Schmid, Cullen L., Acevedo-Canabal, Agnes, Kennedy, Nicole M., Cameron, Michael D., Bannister, Thomas D., Bohn, Laura M.

    Published in Neuropharmacology (01-03-2021)
    “…The mu opioid receptor-selective agonist, SR-17018, preferentially activates GTPγS binding over βarrestin2 recruitment in cellular assays, thereby…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    G protein signaling–biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists by Stahl, Edward L., Schmid, Cullen L., Acevedo-Canabal, Agnes, Read, Cai, Grim, Travis W., Kennedy, Nicole M., Bannister, Thomas D., Bohn, Laura M.

    “…The ability of a ligand to preferentially promote engagement of one signaling pathway over another downstream of GPCR activation has been referred to as…”
    Get full text
    Journal Article
  18. 18

    Inverse Miniemulsion Enables the Continuous-Flow Synthesis of Controlled Ultra-High Molecular Weight Polymers by Davidson, Cullen L. G., Lott, Megan E., Trachsel, Lucca, Wong, Alexander J., Olson, Rebecca A., Pedro, Diego I., Sawyer, W. Gregory, Sumerlin, Brent S.

    Published in ACS macro letters (19-09-2023)
    “…We report the controlled synthesis of ultra-high molecular weight (UHMW) polymers (M n ≥ 106 g/mol) via continuous flow in a tubular reactor. At high monomer…”
    Get full text
    Journal Article
  19. 19

    A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal by Grim, Travis W, Schmid, Cullen L, Stahl, Edward L, Pantouli, Fani, Ho, Jo-Hao, Acevedo-Canabal, Agnes, Kennedy, Nicole M, Cameron, Michael D, Bannister, Thomas D, Bohn, Laura M

    Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2020)
    “…It has been demonstrated that opioid agonists that preferentially act at μ-opioid receptors to activate G protein signaling over βarrestin2 recruitment produce…”
    Get full text
    Journal Article
  20. 20

    A social network perspective on workplace inclusion: The role of network closure, network centrality, and need for affiliation by Grosser, Travis J., Sterling, Christopher M., Piplani, Rohit S., Cullen‐Lester, Kristin L., Floyd, Theresa M.

    Published in Human resource management (01-07-2023)
    “…Organizations are increasingly recognizing the important role employee inclusion perceptions play in promoting positive employee attitudes and behaviors…”
    Get full text
    Journal Article